キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/03/28 | 2,602 | 2,614 | 2,589 | 2,600 | +6 | +0.2% | 60,800 |
2022/03/25 | 2,584 | 2,611 | 2,584 | 2,594 | +42 | +1.6% | 100,200 |
2022/03/24 | 2,563 | 2,563 | 2,506 | 2,552 | -36 | -1.4% | 91,600 |
2022/03/23 | 2,556 | 2,595 | 2,519 | 2,588 | +60 | +2.4% | 99,700 |
2022/03/22 | 2,547 | 2,554 | 2,518 | 2,528 | +12 | +0.5% | 112,800 |
2022/03/18 | 2,511 | 2,519 | 2,476 | 2,516 | +13 | +0.5% | 270,600 |
2022/03/17 | 2,529 | 2,530 | 2,493 | 2,503 | -2 | -0.1% | 141,600 |
2022/03/16 | 2,480 | 2,523 | 2,478 | 2,505 | +45 | +1.8% | 127,300 |
2022/03/15 | 2,452 | 2,475 | 2,441 | 2,460 | +3 | +0.1% | 96,800 |
2022/03/14 | 2,451 | 2,468 | 2,415 | 2,457 | +12 | +0.5% | 105,200 |
2022/03/11 | 2,440 | 2,461 | 2,430 | 2,445 | -15 | -0.6% | 99,300 |
2022/03/10 | 2,411 | 2,460 | 2,391 | 2,460 | +91 | +3.8% | 123,700 |
2022/03/09 | 2,392 | 2,392 | 2,349 | 2,369 | -36 | -1.5% | 145,600 |
2022/03/08 | 2,400 | 2,417 | 2,391 | 2,405 | -9 | -0.4% | 155,600 |
2022/03/07 | 2,360 | 2,417 | 2,360 | 2,414 | +30 | +1.3% | 153,200 |
2022/03/04 | 2,414 | 2,414 | 2,379 | 2,384 | -30 | -1.2% | 108,800 |
2022/03/03 | 2,405 | 2,430 | 2,398 | 2,414 | +30 | +1.3% | 96,600 |
2022/03/02 | 2,394 | 2,401 | 2,379 | 2,384 | -56 | -2.3% | 113,800 |
2022/03/01 | 2,447 | 2,465 | 2,429 | 2,440 | +13 | +0.5% | 131,200 |
2022/02/28 | 2,378 | 2,428 | 2,358 | 2,427 | +58 | +2.4% | 91,300 |
2022/02/25 | 2,413 | 2,427 | 2,364 | 2,369 | -46 | -1.9% | 62,700 |
2022/02/24 | 2,369 | 2,421 | 2,361 | 2,415 | +24 | +1% | 110,400 |
2022/02/22 | 2,381 | 2,398 | 2,354 | 2,391 | -16 | -0.7% | 63,300 |
2022/02/21 | 2,394 | 2,418 | 2,383 | 2,407 | -29 | -1.2% | 65,800 |
2022/02/18 | 2,420 | 2,446 | 2,412 | 2,436 | -7 | -0.3% | 108,800 |
2022/02/17 | 2,473 | 2,473 | 2,425 | 2,443 | -33 | -1.3% | 99,800 |
2022/02/16 | 2,469 | 2,485 | 2,450 | 2,476 | +57 | +2.4% | 92,800 |
2022/02/15 | 2,409 | 2,444 | 2,390 | 2,419 | +24 | +1% | 130,000 |
2022/02/14 | 2,372 | 2,403 | 2,353 | 2,395 | -10 | -0.4% | 79,200 |
2022/02/10 | 2,404 | 2,416 | 2,385 | 2,405 | +27 | +1.1% | 86,200 |
2022/02/09 | 2,390 | 2,406 | 2,376 | 2,378 | -8 | -0.3% | 84,500 |
2022/02/08 | 2,370 | 2,405 | 2,361 | 2,386 | +27 | +1.1% | 86,100 |
2022/02/07 | 2,336 | 2,365 | 2,317 | 2,359 | +15 | +0.6% | 92,000 |
2022/02/04 | 2,337 | 2,361 | 2,311 | 2,344 | -2 | -0.1% | 107,600 |
2022/02/03 | 2,322 | 2,362 | 2,315 | 2,346 | +9 | +0.4% | 76,100 |
2022/02/02 | 2,300 | 2,388 | 2,261 | 2,337 | -6 | -0.3% | 160,600 |
2022/02/01 | 2,355 | 2,373 | 2,324 | 2,343 | +32 | +1.4% | 121,300 |
2022/01/31 | 2,310 | 2,320 | 2,294 | 2,311 | +11 | +0.5% | 61,400 |
2022/01/28 | 2,275 | 2,300 | 2,260 | 2,300 | +84 | +3.8% | 94,400 |
2022/01/27 | 2,251 | 2,258 | 2,201 | 2,216 | -37 | -1.6% | 78,000 |
2022/01/26 | 2,298 | 2,298 | 2,251 | 2,253 | -45 | -2% | 49,600 |
2022/01/25 | 2,310 | 2,320 | 2,279 | 2,298 | -39 | -1.7% | 69,700 |
2022/01/24 | 2,273 | 2,337 | 2,273 | 2,337 | +49 | +2.1% | 54,900 |
2022/01/21 | 2,299 | 2,299 | 2,274 | 2,288 | -1 | ±0% | 63,300 |
2022/01/20 | 2,259 | 2,309 | 2,250 | 2,289 | +43 | +1.9% | 86,200 |
2022/01/19 | 2,290 | 2,299 | 2,240 | 2,246 | -69 | -3% | 90,600 |
2022/01/18 | 2,388 | 2,388 | 2,314 | 2,315 | +2 | +0.1% | 69,900 |
2022/01/17 | 2,312 | 2,315 | 2,287 | 2,313 | +43 | +1.9% | 58,300 |
2022/01/14 | 2,300 | 2,300 | 2,242 | 2,270 | -4 | -0.2% | 69,000 |
2022/01/13 | 2,308 | 2,308 | 2,273 | 2,274 | -27 | -1.2% | 52,200 |
851~
900
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム